EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:ESF0 • FR0014000MR3

67.94 EUR
-0.34 (-0.5%)
Last: Feb 9, 2026, 07:00 PM
Fundamental Rating

5

Overall ESF0 gets a fundamental rating of 5 out of 10. We evaluated ESF0 against 21 industry peers in the Life Sciences Tools & Services industry. ESF0 has an average financial health and profitability rating. ESF0 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ESF0 had positive earnings in the past year.
  • In the past year ESF0 had a positive cash flow from operations.
  • Each year in the past 5 years ESF0 has been profitable.
  • ESF0 had a positive operating cash flow in each of the past 5 years.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • With a decent Return On Assets value of 6.29%, ESF0 is doing good in the industry, outperforming 71.43% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 15.21%, ESF0 is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • ESF0's Return On Invested Capital of 11.61% is fine compared to the rest of the industry. ESF0 outperforms 76.19% of its industry peers.
Industry RankSector Rank
ROA 6.29%
ROE 15.21%
ROIC 11.61%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ESF0 has a worse Profit Margin (6.48%) than 61.90% of its industry peers.
  • ESF0's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 12.42%, ESF0 is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • ESF0's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 22.25%, ESF0 is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ESF0 has declined.
Industry RankSector Rank
OM 12.42%
PM (TTM) 6.48%
GM 22.25%
OM growth 3Y-11.06%
OM growth 5Y-10.4%
PM growth 3Y-9.05%
PM growth 5Y-6.87%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. Health

2.1 Basic Checks

  • ESF0 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • ESF0 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 3.07 indicates that ESF0 is not in any danger for bankruptcy at the moment.
  • With a Altman-Z score value of 3.07, ESF0 perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
  • ESF0 has a debt to FCF ratio of 5.14. This is a neutral value as ESF0 would need 5.14 years to pay back of all of its debts.
  • The Debt to FCF ratio of ESF0 (5.14) is better than 61.90% of its industry peers.
  • ESF0 has a Debt/Equity ratio of 0.82. This is a neutral value indicating ESF0 is somewhat dependend on debt financing.
  • ESF0 has a Debt to Equity ratio of 0.82. This is comparable to the rest of the industry: ESF0 outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 3.07
ROIC/WACC1.23
WACC9.45%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that ESF0 should not have too much problems paying its short term obligations.
  • ESF0's Current ratio of 1.09 is in line compared to the rest of the industry. ESF0 outperforms 47.62% of its industry peers.
  • ESF0 has a Quick Ratio of 1.03. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
  • ESF0 has a Quick ratio of 1.03. This is comparable to the rest of the industry: ESF0 outperforms 47.62% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

  • ESF0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.73%, which is quite good.
  • The Earnings Per Share has been decreasing by -0.23% on average over the past years.
  • Looking at the last year, ESF0 shows a very strong growth in Revenue. The Revenue has grown by 53.32%.
  • ESF0 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.05% yearly.
EPS 1Y (TTM)12.73%
EPS 3Y-4.43%
EPS 5Y-0.23%
EPS Q2Q%6.78%
Revenue 1Y (TTM)53.32%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%

3.2 Future

  • Based on estimates for the next years, ESF0 will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.10% on average per year.
  • ESF0 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.79% yearly.
EPS Next Y10.84%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
EPS Next 5Y15.1%
Revenue Next Year5.78%
Revenue Next 2Y6.35%
Revenue Next 3Y7.37%
Revenue Next 5Y7.79%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.26 indicates a rather expensive valuation of ESF0.
  • Based on the Price/Earnings ratio, ESF0 is valued a bit cheaper than 76.19% of the companies in the same industry.
  • ESF0's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
  • Based on the Price/Forward Earnings ratio of 16.82, the valuation of ESF0 can be described as correct.
  • Based on the Price/Forward Earnings ratio, ESF0 is valued a bit cheaper than the industry average as 76.19% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of ESF0 to the average of the S&P500 Index (27.86), we can say ESF0 is valued slightly cheaper.
Industry RankSector Rank
PE 18.26
Fwd PE 16.82
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaper than 80.95% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ESF0 indicates a rather cheap valuation: ESF0 is cheaper than 90.48% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.34
EV/EBITDA 8.23
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • ESF0's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ESF0's earnings are expected to grow with 15.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.69
PEG (5Y)N/A
EPS Next 2Y12.5%
EPS Next 3Y15.73%

5

5. Dividend

5.1 Amount

  • ESF0 has a Yearly Dividend Yield of 1.05%. Purely for dividend investing, there may be better candidates out there.
  • ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.44. ESF0 pays more dividend than 90.48% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, ESF0's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.05%

5.2 History

  • On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 15.92% of the earnings are spent on dividend by ESF0. This is a low number and sustainable payout ratio.
  • ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP15.92%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

FRA:ESF0 (2/9/2026, 7:00:00 PM)

67.94

-0.34 (-0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)07-21
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.38B
Revenue(TTM)10.66B
Net Income(TTM)691.00M
Analysts68.42
Price Target69.7 (2.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.05%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP15.92%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.45%
PT rev (3m)4.99%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.47%
EPS NY rev (3m)0.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 18.26
Fwd PE 16.82
P/S 1.16
P/FCF 14.34
P/OCF 8.84
P/B 2.72
P/tB N/A
EV/EBITDA 8.23
EPS(TTM)3.72
EY5.48%
EPS(NY)4.04
Fwd EY5.95%
FCF(TTM)4.74
FCFY6.97%
OCF(TTM)7.69
OCFY11.31%
SpS58.51
BVpS24.95
TBVpS-4.41
PEG (NY)1.69
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 6.29%
ROE 15.21%
ROCE 15.48%
ROIC 11.61%
ROICexc 12.8%
ROICexgc 41.1%
OM 12.42%
PM (TTM) 6.48%
GM 22.25%
FCFM 8.1%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.06%
OM growth 5Y-10.4%
PM growth 3Y-9.05%
PM growth 5Y-6.87%
GM growth 3Y-1.72%
GM growth 5Y-3.8%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 1.9
Cap/Depr 85.24%
Cap/Sales 5.04%
Interest Coverage 11.51
Cash Conversion 71.65%
Profit Quality 124.89%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 3.07
F-Score6
WACC9.45%
ROIC/WACC1.23
Cap/Depr(3y)81.48%
Cap/Depr(5y)89.24%
Cap/Sales(3y)7.8%
Cap/Sales(5y)8.16%
Profit Quality(3y)196.03%
Profit Quality(5y)160.87%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-4.43%
EPS 5Y-0.23%
EPS Q2Q%6.78%
EPS Next Y10.84%
EPS Next 2Y12.5%
EPS Next 3Y15.73%
EPS Next 5Y15.1%
Revenue 1Y (TTM)53.32%
Revenue growth 3Y2.82%
Revenue growth 5Y6.05%
Sales Q2Q%4.3%
Revenue Next Year5.78%
Revenue Next 2Y6.35%
Revenue Next 3Y7.37%
Revenue Next 5Y7.79%
EBIT growth 1Y27.19%
EBIT growth 3Y-8.55%
EBIT growth 5Y-4.98%
EBIT Next Year83.08%
EBIT Next 3Y29.99%
EBIT Next 5Y25.16%
FCF growth 1Y9.17%
FCF growth 3Y21.94%
FCF growth 5Y-0.12%
OCF growth 1Y6.15%
OCF growth 3Y7.21%
OCF growth 5Y2.73%

EUROFINS SCIENTIFIC / ESF0.DE FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ESF0.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ESF0.DE.


What is the valuation status for ESF0 stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Fairly Valued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ESF0.DE) is 18.26 and the Price/Book (PB) ratio is 2.72.


How sustainable is the dividend of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 5 / 10 and the dividend payout ratio is 15.92%.